The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $70.39

Today's change+0.23 +0.33%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $70.39

Today's change+0.23 +0.33%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Eli Lilly and Co up (U.S.)$0.23

Eli Lilly and Co closed up Friday by (U.S.)$0.23 or 0.33% to (U.S.)$70.39. Shares have lost 2.78% over the last five days, but have gained 38.02% over the last year to date. This security has outperformed the S&P 500 by 24.65% during the last year.

Key company metrics

  • Open(U.S.) $70.29
  • Previous close(U.S.) $70.16
  • High(U.S.) $70.99
  • Low(U.S.) $70.26
  • Bid / Ask-- / --
  • YTD % change+38.02%
  • Volume1,438,221
  • Average volume (10-day)4,743,725
  • Average volume (1-month)5,270,979
  • Average volume (3-month)4,632,477
  • 52-week range(U.S.) $50.52 to (U.S.) $75.10
  • Beta0.45
  • Trailing P/E28.18×
  • P/E 1 year forward25.33×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.84%
  • Trailing EPS(U.S.) $2.50
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.25%

Based on its net profit margin of 13.25%, Eli Lilly and Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,8764,9364,6835,809
Total other revenue--------
Total revenue4,8764,9364,6835,809
Gross profit3,6093,7463,4604,422
Total cost of revenue1,2671,1901,2231,387
Total operating expense4,3144,0493,8484,908
Selling / general / administrative1,6721,6641,4851,954
Research & development1,2431,1951,1091,475
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)13103193
Other operating expenses, total--------
Operating income562887835901
Interest income (expense), net non-operating-48-45-46-40
Gain (loss) on sale of assets--------
Other--------
Income before tax656940891910
Income after tax501734728728
Income tax, total155207163182
Net income501734728728
Total adjustments to net income--------
Net income before extra. items501734728728
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items501734728728
Inc. avail. to common incl. extra. items501734728728
Diluted net income501734728728
Dilution adjustment--------
Diluted weighted average shares1,0741,0761,0761,079
Diluted EPS excluding extraordinary itemsvalue per share0.470.680.680.67
Dividends per sharevalue per share0.490.490.490.49
Diluted normalized EPSvalue per share0.580.680.700.75